CNBX Pharmaceuticals Inc. (CNBX) stock

CNBXOTCPharmaceutical PreparationsFiscal year ends August 31

Financials through Q3 FY2026, quarter ended May 31, 2026Last filing: 10-Q on Jun 24, 2026Score 0/30

$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $197.79KP/E –Yield –

CNBX Pharmaceuticals ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

CNBX Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Parsed from the XBRL in CNBX Pharmaceuticals's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-120 reverse split on May 12, 2022
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is CNBX.

Advertisement
300 × 250

See a number that looks wrong?